Fig. 5From: Biologic use and treatment patterns in patients with chronic rhinosinusitis with nasal polyps: a US real-world studyPredictors of biologic use among patients without biologic use during the identification period (N = 5610). All covariates with P < 0.05 for entry into the model using stepwise regression are shown. Covariates and odds ratios in bold and blue text signify P < 0.05 from the regression model. *OCS use based on patients with ≥ 1 pharmacy claim for OCS. CI, confidence interval; CT, computed tomography; GERD, gastroesophageal reflux disease; OCS, oral corticosteroidBack to article page